Ambulatory and Enterprise EMR Interoperability 2023
Are Deep Adopters Close to the Ideal?

Author
Coray Tate

Author
Paul Warburton

March 16, 2023 | Read Time: 7 minutes

Interoperability is a continued area of critical focus for the healthcare industry. There is no question that progress is being made, but there is still significant room for improvement. For this report, KLAS talked to vendor-identified deep adopters to take a holistic look at the current state of interoperability in ambulatory and enterprise EMRs and measure how close we are to an ideal state. The results reveal each vendor’s strengths and weaknesses within various areas of interoperability.

to see the full dataset.

If you don't have a login, getting started is easy.

Provider Organizations

Fill out our registration form to verify your organization.

HIT Companies

Contact a KLAS representative for plans and pricing.

Key Findings:

Market Overview: Moving Forward Will Require Cooperation between All Stakeholders
Connectivity: Epic and Oracle Health (Cerner) Customers Lead in FHIR API Adoption to Support Third-Party Connectivity
Utility: Duplicate Data a Major Issue; NextGen Healthcare Has Made Notable Progress
Use Cases: NextGen Healthcare Leading in Making External Data Actionable; Altera Digital Health (Allscripts), eClinicalWorks, and Greenway Health Falling Behind
Outcomes: Organizations Starting to See Real Outcomes as Interoperability Advances

Writer
Carlisa Cramer

Designer
Bronson Allgood

Project Manager
Andrew Wright

Download Report Brief Download Full Report

This material is copyrighted. Any organization gaining unauthorized access to this report will be liable to compensate KLAS for the full retail price. Please see the KLAS DATA USE POLICY for information regarding use of this report. © 2024 KLAS Research, LLC. All Rights Reserved. NOTE: Performance scores may change significantly when including newly interviewed provider organizations, especially when added to a smaller sample size like in emerging markets with a small number of live clients. The findings presented are not meant to be conclusive data for an entire client base.